Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Zaanan

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Journal of Hepatology|September 20, 2012
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO studyAziz Zaanan, Nicolas Williet, Mohamed Hebbar, et al.
British Journal of Cancer|June 7, 2018
Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre studySimon Pernot, Olivier Dubreuil, Thomas Aparicio, et al.
BMC Cancer|June 16, 2014
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM studyAziz Zaanan, Isabelle Trouilloud, Theofano Markoutsaki, et al.
European Journal of Cancer (Oxford, England : 1990)|January 9, 2023
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiencyMarie-Christine Etienne-Grimaldi, Nicolas Pallet, Valérie Boige, et al.
British Journal of Cancer|November 24, 2017
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective studyMaëva Salimon, Caroline Prieux-Klotz, David Tougeron, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2018
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)Aziz Zaanan, Emmanuelle Samalin, Thomas Aparicio, et al.
Journal of the National Cancer Institute|May 17, 2020
Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial OriginAziz Zaanan, Julie Henriques, Romain Cohen, et al.
Therapeutic Advances in Gastroenterology|August 11, 2020
Effectiveness of a dedicated small bowel neoplasia screening program by capsule endoscopy in Lynch syndrome: 5 years results from a tertiary care centerGuillaume Perrod, Elia Samaha, Enrique Perez-Cuadrado-Robles, et al.
Clinics and Research in Hepatology and Gastroenterology|March 31, 2021
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH surveyDebora Basile, Claire Gallois, Fabio Puglisi, et al.
International Journal of Cancer|September 1, 2019
Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancerEmilie Moati, Hélène Blons, Valerie Taly, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|September 20, 2012
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO studyAziz Zaanan, Nicolas Williet, Mohamed Hebbar, et al.
British Journal of Cancer|June 7, 2018
Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre studySimon Pernot, Olivier Dubreuil, Thomas Aparicio, et al.
BMC Cancer|June 16, 2014
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM studyAziz Zaanan, Isabelle Trouilloud, Theofano Markoutsaki, et al.
European Journal of Cancer (Oxford, England : 1990)|January 9, 2023
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiencyMarie-Christine Etienne-Grimaldi, Nicolas Pallet, Valérie Boige, et al.
British Journal of Cancer|November 24, 2017
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective studyMaëva Salimon, Caroline Prieux-Klotz, David Tougeron, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2018
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)Aziz Zaanan, Emmanuelle Samalin, Thomas Aparicio, et al.
Journal of the National Cancer Institute|May 17, 2020
Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial OriginAziz Zaanan, Julie Henriques, Romain Cohen, et al.
Therapeutic Advances in Gastroenterology|August 11, 2020
Effectiveness of a dedicated small bowel neoplasia screening program by capsule endoscopy in Lynch syndrome: 5 years results from a tertiary care centerGuillaume Perrod, Elia Samaha, Enrique Perez-Cuadrado-Robles, et al.
Clinics and Research in Hepatology and Gastroenterology|March 31, 2021
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH surveyDebora Basile, Claire Gallois, Fabio Puglisi, et al.
International Journal of Cancer|September 1, 2019
Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancerEmilie Moati, Hélène Blons, Valerie Taly, et al.
Pageof 14